Notice of Meeting, 3428 [2023-00911]
Download as PDF
<![CDATA[
3428
Federal Register / Vol. 88, No. 12 / Thursday, January 19, 2023 / Notices
available at the Committee’s website:
https://www.samhsa.gov/about-us/
advisory-councils/ismicc.
Dated: January 12, 2023.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2023–00916 Filed 1–18–23; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention’s
(CSAP) Drug Testing Advisory Board
(DTAB) will convene via web
conference on March 7, 2023, from 10
a.m. EST to 4:30 p.m. EST.
The board will meet in open-session
March 7, 2023, from 10 a.m. EST to 2
p.m. EST to discuss the Mandatory
Guidelines for Federal Workplace Drug
Testing Programs, updates to the
Electronic Chain of Custody Form
(ECCF), as well as updates from the
Department of Transportation, the
Nuclear Regulatory Commission, the
Department of Defense, and the Food
and Drug Administration as well as a
presentation by Dr. Svante Vikingsson
on Fentanyl and Opioids Pulse Study
results.
The board will meet in closed session
on March 7, 2023, from 2:15 p.m. EST
to 4:30 p.m. EST to discuss issues
surrounding cannabinoids pertaining to
the effect of the proliferation of various
cannabinoid isomers, including Delta–
8–THC, on federal workplace drug
testing programs, including federal and
state responses to cannabinoid drug
testing issues of concern, and potential
SAMSHA actions. In closed session the
board will also review information and
proposed actions concerning the
Department of Health and Humans
Services (HHS) Mandatory Guideline
internal review and approval process
that has not been made public by HHS.
Therefore, the March 7, 2023, meeting
from 2:15 p.m. to 4:30 p.m. is closed to
the public, as determined by the
Assistant Secretary for Mental Health
and Substance Use, SAMHSA, in
accordance with 5 U.S.C. 552b(c)(9)(B)
and 5 U.S.C. App. 2, section 10(d).
Meeting registration information can
be completed at https://
snacregister.samhsa.gov/. Web
conference and call information will be
VerDate Sep<11>2014
17:49 Jan 18, 2023
Jkt 259001
sent after completing registration.
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committees website, https://
www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting the
Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: March 7, 2023,
from 10 a.m. EST to 2 p.m. EST: OPEN;
March 7, 2023, from 2:15 p.m. EST to
4:30 p.m. EST: CLOSED.
Place: Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857.
Contact: Lisa S. Davis, M.S., Social
Science Analyst, Center for Substance
Abuse Prevention, 5600 Fishers Lane,
Rockville, Maryland 20857, Telephone:
(240) 276–1440, Email: Lisa.Davis@
samhsa.hhs.gov.
Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace
Programs.
[FR Doc. 2023–00911 Filed 1–18–23; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R1–ES–2022–0169; ES11140100000–
234–FF01E0000]
Candidate Conservation Agreement
With Assurances for the Fisher in
Oregon; Enhancement of Survival
Permit Applications; Hampton and
Starker Site Plans
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability; request
for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service (Service), received two
enhancement of survival permit (permit)
applications pursuant to the Endangered
Species Act (ESA). If granted, the
requested permits would authorize take
of the fisher (Pekania pennanti),
incidental to otherwise lawful activities,
if the species becomes federally listed
under the ESA. These applications are
associated with a template candidate
conservation agreement with assurances
(CCAA) developed by the Service for the
conservation of the fisher. We have also
prepared draft environmental action
statements documenting our
preliminary determination that the
permit decisions may be eligible for
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
categorical exclusion under the National
Environmental Policy Act. We provide
this notice to open a public comment
period and invite comments from all
interested parties.
DATES: Submit written comments no
later than February 21, 2023.
ADDRESSES:
Obtaining Documents: The
applications, application supporting
materials, and any comments and other
materials that we receive will be
available for public inspection at
https://www.regulations.gov in Docket
No. FWS–R1–ES–2022–0169.
Submitting Comments: To submit
written comments, please use one of the
following methods:
• Internet: https://
www.regulations.gov. Search for and
submit comments on Docket No. FWS–
R1–2022–0169.
• U.S. Mail: Attn: Docket No. FWS–
R1–ES–2022–0169; U.S. Fish and
Wildlife Service Headquarters, MS:
PRB/3W; 5275 Leesburg Pike, Falls
Church, VA 22041–3803.
For more information, see Public
Availability of Comments under
SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT:
Frank Weaver, via telephone at 541–
957–3471, or via email at Frank_
Weaver@fws.gov. Individuals in the
United States who are deaf, deafblind,
hard of hearing, or have a speech
disability may dial 711 (TTY, TDD, or
TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
SUPPLEMENTARY INFORMATION: We, the
U.S. Fish and Wildlife Service (Service),
have received two enhancement of
survival permit (permit) applications
pursuant to section 10(a)1(A) of the
Endangered Species Act of 1973, as
amended (ESA; 16 U.S.C. 1531 et seq.).
The two applicants are Hampton
Lumber (Hampton) and Starker Forest
Inc./Starker Properties LLC (Starker).
If granted, either or both of the
requested permits would authorize take
of the fisher (Pekania pennanti)
incidental to the applicants’ routine
forest-related management activities, if
the species becomes federally listed
under the ESA. Each application
includes a proposed individual site plan
developed under a template candidate
conservation agreement with assurances
(CCAA) developed by the Service in
2018 for the conservation of the fisher.
The conservation measures in the CCAA
are intended to provide a net
E:\FR\FM\19JAN1.SGM
19JAN1
]]>Agencies
[Federal Register Volume 88, Number 12 (Thursday, January 19, 2023)]
[Notices]
[Page 3428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00911]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory
Board (DTAB) will convene via web conference on March 7, 2023, from 10
a.m. EST to 4:30 p.m. EST.
The board will meet in open-session March 7, 2023, from 10 a.m. EST
to 2 p.m. EST to discuss the Mandatory Guidelines for Federal Workplace
Drug Testing Programs, updates to the Electronic Chain of Custody Form
(ECCF), as well as updates from the Department of Transportation, the
Nuclear Regulatory Commission, the Department of Defense, and the Food
and Drug Administration as well as a presentation by Dr. Svante
Vikingsson on Fentanyl and Opioids Pulse Study results.
The board will meet in closed session on March 7, 2023, from 2:15
p.m. EST to 4:30 p.m. EST to discuss issues surrounding cannabinoids
pertaining to the effect of the proliferation of various cannabinoid
isomers, including Delta-8-THC, on federal workplace drug testing
programs, including federal and state responses to cannabinoid drug
testing issues of concern, and potential SAMSHA actions. In closed
session the board will also review information and proposed actions
concerning the Department of Health and Humans Services (HHS) Mandatory
Guideline internal review and approval process that has not been made
public by HHS. Therefore, the March 7, 2023, meeting from 2:15 p.m. to
4:30 p.m. is closed to the public, as determined by the Assistant
Secretary for Mental Health and Substance Use, SAMHSA, in accordance
with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, section 10(d).
Meeting registration information can be completed at https://snacregister.samhsa.gov/. Web conference and call information will be
sent after completing registration. Meeting information and a roster of
DTAB members may be obtained by accessing the SAMHSA Advisory
Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings, or by contacting the Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse and Mental Health Services
Administration, Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: March 7, 2023, from 10 a.m. EST to 2 p.m. EST:
OPEN; March 7, 2023, from 2:15 p.m. EST to 4:30 p.m. EST: CLOSED.
Place: Substance Abuse and Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD 20857.
Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland
20857, Telephone: (240) 276-1440, Email: [email protected].
Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2023-00911 Filed 1-18-23; 8:45 am]
BILLING CODE 4162-20-P
